BrianLeslieBurnetteMD

Oncology • Green Bay, WI

Physician

Join to view full profile

Are you Dr. Burnette?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 103 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
835 S Van Buren St
Green Bay, WI 54301
Phone+1 920-432-6049

Summary

Dr. Brian Burnette, MD is an oncologist in Green Bay, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Michigan, and Minnesota. He is affiliated with HSHS St. Vincent Hospital, HSHS St. Clare Memorial Hospital, and OSF St. Francis Hospital and Medical Group.

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Michigan State University College of Human MedicineClass of 2006

Certifications & Licensure

MI State Medical License 2013 - 2026
WI State Medical License 2013 - 2025
MN State Medical License 2007 - 2014
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18
Active, not recruiting
Phase 2
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Exploring Gender Differences in Receipt of the 5As for Smoking Cessation for Recently-Diagnosed Cancer Patients (ECOG-ACRIN EAQ171CD).
Lucy Finkelstein-Fox, Jo Rean D Sicks, Lynne I Wagner, Ruth C Carlos, Isabelle Miranda
Nicotine & Tobacco Research. 2024-12-19
Personalized Outcomes in Neuropathic Pain: A Clinical Relevance and Assay Sensitivity Analysis from a Randomized Controlled Trial.
Karim Saab, Umang Gada, Eva Culakova, Brian Burnette, Carla Jorgensen
Pain Medicine. 2024-10-04
Exploring the reliability and validity of clinically-relevant outcome measures for chemotherapy-induced peripheral neuropathy.
Robert Knoerl, Michael B Sohn, Kevin Spath, Brian Burnette, Lori Francar
Supportive Care in Cancer. 2024-09-19